Hemay007

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHemay007
Drug Alias NameHemay-007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, UlcerativeArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTianjin Hemay Bio-Tech Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTianjin Hemay Bio-Tech Co LtdTianjin Hemay Pharmaceutical Co LtdXiajiang Hemei Pharmaceutical Co Ltd
Inactive CompaniesHemay Pharmaceutical Pty Ltd
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsInflammatory Bowel DiseasesColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A